Committee on Safety of Medicines
 |
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
The Committee on the Safety of Medicines (CSM) was an independent advisory committee that for 40 years advised the UK Licensing Authority on the quality, efficacy and safety of medicines.
Following the thalidomide tragedy of 1957 to 1961, in 1963 the government asked Sir Derrick Dunlop to set up a committee to investigate the control and introduction of new medicines in to the United Kingdom. As a result of the subsequent report to the Department of Health, which reinforced the need for specially trained doctors in the pharmaceutical industry and academic departments of medicine, Dunlop became the first chairman of the committee.[1]
It was replaced on 30 October 2005 by the Commission on Human Medicines which combines the functions of both the former committee and the Medicines Commission.
[edit] See also
[edit] References
- ^ "History and Aims of the Faculty of Pharmaceutical Medicine". Royal College of Physicians. http://www.fpm.org.uk/faculty/history. Retrieved 2010-05-20.
